VerAvanti Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 20
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 2

VerAvanti General Information


Developer of a sub-milimeter device designed to treat stroke and cardiovascular events. The company's advanced, laser-based medical camera systems use Scanning Fiber Endoscope technology to provide physicians with a real-time, high-resolution, surgical view into the hidden intra-vascular anatomy enabling them to visually identify potential risks for stroke and cardiovascular risks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 2260 152nd Avenue North East
  • Suite 200
  • Redmond, WA 98052
  • United States
+1 (425) 000-0000

VerAvanti Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VerAvanti Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 29-Apr-2020 00.000 Completed
4. Capitalization 17-Jul-2017 000 00.000 Completed Startup
3. Angel (individual) 25-May-2017 00000 00000 Completed Startup
2. Grant 01-Jan-2017 $586K Completed Startup
1. Accelerator/Incubator 28-Jun-2014 Completed Startup
To view VerAvanti’s complete valuation and funding history, request access »

VerAvanti Executive Team (2)

Name Title Board Seat Contact Info
Gerald McMorrow Founder, Board Member & Chief Executive Officer
Russell Garrison President, Board Member & Chief Operating Officer
To view VerAvanti’s complete executive team members history, request access »

VerAvanti Board Members (1)

Name Representing Role Since
David Auth VerAvanti Board Member 000 0000
To view VerAvanti’s complete board members history, request access »

VerAvanti Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VerAvanti Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
UW CoMotion Accelerator/Incubator 000 0000 000000 0
To view VerAvanti’s complete investors history, request access »